Figure 1.
Treatment recommendations for rash mediated by monoclonal antibody targeting of epidermal growth factor receptor, by severity (Adapted from the BC Cancer Agency’s EGFR inhibitors rash protocol.)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.